Clinical Trials in Houston

Showing 1821-1840 of 15,366 trials

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

NCT07195916

A study to evaluate the safety and tolerability of INCA036873 in participants with advanced solid tumors and hematological malignancies.

Solid TumorsHematologic Malignancies

Incyte Corporation280 participantsStarted Jan 2026

Duarte, California, United States • La Jolla, California, United States • Ann Arbor, Michigan, United States +19 more locations

RECRUITINGPhase 1< 1 mile

ORB-021 In Patients With Advanced Solid Tumors

NCT06607939

The goal of this clinical research study is to determine if an investigational new drug, named ORB-021, developed by Orionis Biosciences is safe and can be tolerated in people diagnosed with an advanced solid tumor. The study also aims to find the biologically optimal dose of the study medicine by assessing the safety and potential activity in the treatment of solid tumors. There are three phases to this study: screening, treatment and end of treatment.

Advanced Solid Tumors Cancer

Orionis Biosciences Inc36 participantsStarted Nov 2024

Scottsdale, Arizona, United States • Houston, Texas, United States

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

ORB-021 In Patients With Advanced Solid Tumors

Find Trials by Condition in Houston

A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

Randomized Clinical Trial for Ewing Amputation in the VA

Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (Pilot)

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism

Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations

Global Registry for Endovascular Aortic Treatment (GREAT)

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis

Study of ATX-01 in Participants With DM1

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib